Anna M. Dabrowska
Jaczewskiego Street 8b
Lublin, LU 20090, Poland
Lublin, LU 20090, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Activation of Brown Adipocytes by Farnesoid X Receptor Agonist, Obeticholic Acid-A Potential Novel Therapeutic Avenue in the Management of Obesity.
Journal: Journal of clinical medicine
Published: March 19, 2026
Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders.
Journal: Drug discovery today
Published: January 09, 2025
Enhancing the stereoselectivity of Me2GaOR(NHC) species in the ring-opening polymerization of rac-lactide, with the help of the chelation effect.
Journal: RSC advances
Published: July 22, 2024
Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug.
Journal: Journal of clinical medicine
Published: October 17, 2023
Inter-comparison of marine microbiome sampling protocols.
Journal: ISME communications
Published: January 31, 2023
Bioaccumulation of PCBs, HCB and PAHs in the summer plankton from West Spitsbergen fjords.
Journal: Marine pollution bulletin
Published: September 23, 2021
Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature.
Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Published: October 21, 2014
Soluble Klotho protein as a novel serum biomarker in patients with acromegaly.
Journal: Archives of medical science : AMS
Published: March 03, 2014
Thyroid diseases in patients with acromegaly.
Journal: Archives of medical science : AMS
Published: January 13, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026